UK Bariatric Surgery Devices Market Analysis

UK Bariatric Surgery Devices Market Executive Summary

The UK Bariatric Surgery Devices Market is at around $212.8 Mn in 2023 and is projected to reach $303.4 Mn in 2030, exhibiting a CAGR of 5.2% during the forecast period 2023-2030.

The goal of bariatric or metabolic surgery, which includes gastric bypass and other weight-reduction procedures, is to modify the digestive system in order to aid in weight loss. These procedures are usually taken into consideration after diet and exercise have failed or when being overweight causes major health problems. Some operations limit the amount of food that may be eaten, while others lessen the body's capacity to absorb calories and fats. Certain techniques integrate both strategies. While there are many advantages to bariatric surgery, it's vital to remember that all weight-loss surgeries are serious operations with possible dangers and adverse effects. To ensure the long-term success of the surgery, patients must also pledge to engage in regular physical activity and make lasting good dietary modifications. While bariatric surgery can offer many benefits, all forms of weight-loss surgery are major procedures that can pose risks and side effects. Also, you must make permanent healthy changes to your diet and get regular exercise to help ensure the long-term success of bariatric surgery. Bariatric surgery is done to help you lose extra weight and reduce your risk of possibly life-threatening weight-related health problems, including: certain cancers, including breast, endometrial and prostate cancer, heart disease and stroke, high blood pressure, high cholesterol levels, Non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH), sleep apnoea, type 2 diabetes etc.

In the UK it's estimated that around 1 in every 4 adults and around 1 in every 5 children aged 10 to 11 are living with obesity. The Health Survey for England 2021 estimates that 25.9% of adults in England are obese and a further 37.9% are overweight. Therefore, the market is driven by various factors such as increasing demand for minimally invasive surgeries, rising incidence of obesity, technological advancements, rising awareness about bariatric surgery.

The prominent players in the market are Apollo Endosurgery, Medtronic, B. Braun, Johnson & Johnson, Aspire Bariatrics among others.

Market Dynamics

Market Drivers

Rising obesity rates in UK: UK has been experiencing a steady increase in obesity rates over the past few decades. The Health Survey for England 2021 estimates that 25.9% of adults in England are obese and a further 37.9% are overweight. This trend is likely to continue, creating a larger potential patient pool for bariatric surgeries and driving demand for related devices.

Government Initiatives: The UK government is implementing health programs aimed at reducing obesity and promoting healthier lifestyles. Initiatives like the "Obesity Strategy" aim to tackle obesity through various measures, including improving access to weight loss surgery.

Technological Advancements: Innovations in surgical techniques, particularly minimally invasive procedures, are making bariatric surgery safer and more effective. The introduction of robotic-assisted surgeries is also enhancing precision and patient outcomes.

Market Restraints

High Costs of Surgery: The high expense of bariatric operations and gadgets remains a major barrier for many patients, even with advances in coverage. This is particularly the case for people living in provinces with little public funding for these treatments or without full insurance coverage. Thus, limiting the adoption of the treatment.

Potential complications: Concerns about potential complications and the need for ongoing medical care after surgery may deter patients from opting for bariatric procedures. Complications can include infections, nutritional deficiencies, and gastrointestinal issues.

Limited availability of skilled bariatric surgeons: There's a shortage of surgeons specially trained in bariatric procedures in UK, leading to long wait times in some regions. This shortage limits market growth and patient access to these treatments.

Regulatory Landscape and Reimbursement Scenario

Medicines and Healthcare products Regulatory Agency (MHRA), which ensures that these devices meet safety, quality, and performance standards before they can be marketed. The regulatory framework is influenced by European Union regulations, including the Medical Devices Regulation (MDR), even after Brexit. Devices are classified based on their risk level, with most bariatric devices falling into Class IIa or IIb, requiring a conformity assessment to demonstrate compliance. This process includes clinical evaluations and adherence to relevant standards, culminating in the necessary CE marking to indicate safety and effectiveness. Post-market surveillance is also mandated to monitor device performance and report adverse events.

The NHS covers bariatric surgery for patients who meet certain criteria, including a BMI over 40 or between 35-40 with serious health conditions like type 2 diabetes. Patients must have tried other weight loss methods without success and agree to long-term lifestyle changes. Many private health insurance plans in the UK cover bariatric surgery, but coverage varies by insurer and policy. Factors like BMI thresholds, previous weight loss attempts, and the presence of obesity-related conditions impact coverage decisions.

Competitive Landscape

Key Players

Here are some of the major key players in the UK Bariatric Surgery Devices Market:

• Apollo EndoSurgery
• Johnson & Johnson
• Entero Healthcare
• Aspire Bariatrics
• Medtronic plc.
• ReShape Medical
• Allergenc Inc
• TransEnterrix
• Stryker
• B Braun